Blog

Eytan Ruppin: The first AI to discover spatial biomarkers for cancer treatment

Photo taken from Eytan Ruppin/X

Oct 21, 2024, 13:57

Eytan Ruppin: The first AI to discover spatial biomarkers for cancer treatment

Eytan Ruppin, Chief of the Cancer Data Science Laboratory, shared on X:

”Proud to launch Path to Space — the first AI to discover spatial biomarkers for cancer treatment! It predicts spatial gene expression from histopathology, enabling large-scale tumor microenvironment profiling.”

Path2Space: An AI Approach for Cancer Biomarker Discovery Via Histopathology Inferred Spatial Transcriptomics

Authors: Eldad David Shulman, Emma M Campagnolo, Roshan Lodha, Thomas Cantore, Tom Hu, Maclean Nasrallah, Danh-Tai Hoang, Kenneth Aldape, Eytan Ruppin.

biomarkers for cancer treatment cancer Danh-Tai Hoang Eldad David Shulman Emma M Campagnolo Eytan Ruppin histopathology Kenneth Aldape Maclean Nasrallah OncoDaily Oncology Path to Space Roshan Lodha Thomas Cantore Tom Hu tumor microenvironment profiling

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage